Skip to Content

Dalbavancin Side Effects

For the Consumer

Applies to dalbavancin: intravenous powder for solution

Along with its needed effects, dalbavancin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking dalbavancin:

Less Common or Rare

  • Abdominal or stomach pain or tenderness
  • back pain
  • black, tarry stools
  • bleeding gums
  • blood in the urine or stools
  • chest pain or tightness
  • chills
  • clay colored stools
  • cough
  • dark urine
  • decreased appetite
  • difficulty swallowing
  • dizziness
  • fast heartbeat
  • feeling of warmth
  • fever
  • headache
  • hives, welts, itching, or rash
  • loss of appetite
  • painful or difficult urination
  • pale skin
  • pinpoint red spots on the skin
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • redness of the face, neck, arms, and occasionally, upper chest
  • redness of the skin
  • severe abdominal or stomach cramps and pain
  • sore mouth or tongue
  • sore throat
  • sores, ulcers, or white spots on the lips or in the mouth
  • swelling of the feet or lower legs
  • swollen glands
  • tightness in the chest
  • troubled breathing with exertion
  • unusual bleeding or bruising
  • unusual tiredness or weakness
  • vomiting of blood or material that looks like coffee grounds
  • watery and severe diarrhea, which may also be bloody
  • yellow eyes or skin

Some side effects of dalbavancin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less Common

  • Diarrhea

Less Common or Rare

For Healthcare Professionals

Applies to dalbavancin: intravenous powder for injection

General

The most common adverse reactions were nausea, headache, and diarrhea.[Ref]

Cardiovascular

Frequency not reported: Anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, international normalized ratio increased, phlebitis, wound hemorrhage, spontaneous hematoma[Ref]

Dermatologic

Common (1% to 10%): Rash, pruritus

Frequency not reported: Urticaria, flushing[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, diarrhea, vomiting

Frequency not reported: Gastrointestinal hemorrhage, melena, hematochezia, abdominal pain[Ref]

Hepatic

Frequency not reported: Hepatotoxicity, hepatic transaminases increased, blood alkaline phosphatase increased[Ref]

Hypersensitivity

Frequency not reported: Anaphylactoid reaction[Ref]

Immunologic

Frequency not reported: Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection[Ref]

Local

Frequency not reported: Infusion-related reactions[Ref]

Metabolic

Frequency not reported: Hypoglycemia[Ref]

Nervous system

Common (1% to 10%): Headache

Frequency not reported: Dizziness[Ref]

Respiratory

Frequency not reported: Bronchospasm[Ref]

References

1. "Product Information. Dalvance (dalbavancin)." Durata Therapeutics, Inc., Chicago, IL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide